Trial by Fire - Did Texas execute an innocent man?

The fire moved quickly through the house, a one-story wood-frame structure in a working-class neighborhood of Corsicana, in northeast Texas. Flames spread along the walls, bursting through doorways, blistering paint and tiles and furniture. Smoke pressed against the ceiling, then banked downward, seeping into each room and through crevices in the windows, staining the morning sky.
Buffie Barbee, who was eleven years old and lived two houses down, was playing in her back yard when she smelled the smoke. She ran inside and told her mother, Diane, and they hurried up the street; that’s when they saw the smoldering house and Cameron Todd Willingham standing on the front porch, wearing only a pair of jeans, his chest blackened with soot, his hair and eyelids singed. He was screaming, “My babies are burning up!” His children—Karmon and Kameron, who were one-year-old twin girls, and two-year-old Amber—were trapped inside.
Willingham told the Barbees to call the Fire Department, and while Dia…

USA: Why the execution drug shortage won't go away

Lethal injections
In a few weeks, the U.S. Supreme Court will hear Glossip vs. Gross, which examines the use of the drug midazolam in lethal injection executions. The case comes on the heels of an infamously gruesome 2014, a year that saw botched executions in Ohio, Oklahoma and Arizona.

The states' problems stem from their increasing difficulty obtaining effective, reliable, FDA-approved drugs to use in lethal injections. The reason is simple: Drug companies don't want their products used to kill people.

But that's not what we're told by state officials. They claim the shortage is strictly the result of anti-death penalty activists harassing the drug companies into abandoning the use of their products in executions. Last year in Ohio, for example, new state laws were drafted to shield the identities of suppliers of lethal injection drugs. State officials maintain that if they can just keep information about the drugs secret, they can ensure a steady supply of approved drugs.

It's true that drug companies have heard from anti-death penalty advocates, but those same companies - and their shareholders and customers - have long objected to the use of their products in executions, as a reflection of both their values and a concern for their bottom line.

The widespread recent issues with obtaining reliable lethal injection drugs began when the U.S. pharmaceutical company Hospira stopped manufacturing FDA-regulated thiopental in 2010 because of a production problem at one of its plants. At the time, thiopental was the anesthetic widely approved by states as part of their 3-drug protocol for executions.

In March of that year, Hospira had requested that prison officials in multiple states discontinue the use of thiopental in executions. "Hospira provides these products because they improve or save lives and markets them solely for use as indicated on the product labeling," the company wrote. "As such, we do not support the use of any of our products in capital punishment procedures."

When Hospira discontinued thiopental, some states began to quietly buy unregulated, non-FDA approved thiopental from a wholesaler in London. In 2010, Britain responded by implementing an export control on thiopental; this control was later adopted more generally by the European Union, none of whose members practice capital punishment. Eventually, a federal appeals court in Washington shut down importation of unapproved thiopental altogether.

This has caused state officials to change their protocols, experimenting with whatever anesthetics and sedatives they were able to obtain at a given moment. (Midazolam, which isn't specified for use as an anesthetic, is one of the alternates that states have tried, ushering in the Supreme Court case.) At every turn, as protocols have changed - and even before thiopental became unavailable - drug companies have tried to figure out how to prevent their products from being used in American executions.

As early as 2001, pharmaceutical companies such as Abbott Laboratories and Baxter International publicly condemned the use of their products in capital punishment. At the time, they were unable to develop distribution controls to prevent prisons from using the drugs.

In January 2011, the president of the Danish pharmaceutical manufacturer Lundbeck wrote to the top prison official of Ohio: "We urge you to discontinue the use of Nembutal [another anesthetic alternative] in the execution of prisoners in your state because it contradicts everything we are in business to do - provide therapies that improve peoples lives."

Such statements show that corporate leaders are convinced that using their medical products to induce death does not comport with the mission or financial interests of their companies. As the investment firm DJE Kapital stated in 2014 when it divested $70 million from Mylan, which produces the paralytic agent used in some lethal injection executions, "If clients find out we have shares in companies that supply that drug, we have problems with our clients."

Shrouding the execution process in secrecy may keep problematic executions out of the public eye, but it will not increase the availability of drugs for use in executions. There is no indication that drug companies are looking to get around the export and import barriers that have been erected. Instead, the problem facing states is more fundamental: They are seeking to impose the death penalty despite a global economic context in which much of the rest of the modern world abhors the practice. As long as that is the case, they are going to have problems finding pharmaceutical products to carry out executions.

Source: Los Angeles Times, Ty Alper, April 13, 2015. Mr. Alper is a clinical professor of law at UC Berkeley and author of "The United States Execution Drug Shortage: A Consequence of Our Values," published in the biannual Brown Journal of World Affairs.

Report an error, an omission: deathpenaltynews@gmail.com

Most Viewed (Last 7 Days)

Iran: Three Hand Amputations, Four Hangings Carried Out in Qom

Iran: Woman Asylum Seeker Lashed 80 Times After Being Deported From Norway

Iran: Three executions carried out, two in front of large crowds

Gambia: President Barrow Signs Abolition Of Death Penalty Treaty

Trial by Fire - Did Texas execute an innocent man?

Texas Child Killer John Battaglia Found Competent for Execution

Two Myanmar migrants make final appeal in Koh Tao murder case

Judge warns death row inmate to keep Nevada's execution manual secret

Seventeen Hanged in Various Iranian Prisons, One in Public

Kenya: Man to hang for stealing toothpaste and toothbrush